It was found that nordentatin inhibited the proliferation and migration of SH-SY5Y cells by inhibiting GSK-3 phosphorylation, which controls the expression of Mcl-1 (antiapoptotic protein), resulting in the activation of cleaved caspase-3 and the apoptosis of cancer cells. Here, CASP3 is linked to cancer.